- Coordinator
- Universite Lyon 1 Claude Bernard, France
- Runs
- 1 November 2025 to 30 April 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101248616
What the project is doing
In the project's own words, from its summary on CORDIS.
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical technique in chemistry, pharmaceuticals, and metabolomics, but requires complex and expensive infrastructure, limiting its widespread adoption. Since recently, the development of Benchtop NMR spectrometers offers a simple, compact, and low-cost alternative compared to traditional high-field systems, and their market has seen a significant growth. However, benchtop NMR faces a critical restraint which is its order of magnitude lower sensitivity.
Hyperpolarization by dissolution dynamic nuclear polarization (dDNP) offers a solution by dramatically enhancing NMR signal strength but is limited to a handful of groups due to its complexity and dramatic costs, as it operates at high-fields and very low temperatures. The BenchHyp project introduces a breakthrough approach by developing a compact, reusable, and scalable hyperpolarization system compatible with benchtop NMR spectrometers.
The core innovation is a flow cryostat with a sliding-sample mechanism, enabling continuous hyperpolarization without sample destruction or dilution. Unlike conventional dDNP, BenchHyp allows multiple reuses of hyperpolarized solutions, significantly reducing costs and enabling real-time, repeated measurements for applications in chemical analysis, pharmaceutical quality control, and metabolomics. This Proof of Concept will advance the technology from TRL 2 to TRL 4, focusing on prototype optimization, industrial validation, and market assessment.
The project will also explore commercialization pathways, evaluating licensing, co-development with industry, or a spin-off. An IP strategy and freedom-to-operate analysis will be conducted to safeguard the innovation. BenchHyp has the potential to revolutionize benchtop NMR, bridging the gap between cutting-edge hyperpolarization and routine laboratory applications, paving the way for its widespread industrial adoption and market deployment.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite Lyon 1 Claude Bernard | Villeurbanne Cedex | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI